Skip to content

Clinical trials

Phase 2 Inflammation trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2 Country / region: Brazil Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20091
20122
20131
20181
20211
20223
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Active, not recruiting3
Completed3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Apsen Farmaceutica S.A.2
Novo Nordisk A/S2
Universidade Federal Fluminense2
AstraZeneca1
Federal University of Latin American Integration1
Hospital de Clinicas de Porto Alegre1
Instituto de Cardiologia do Rio Grande do Sul1
Universidade Federal do Rio de Janeiro1
University of Sao Paulo1
University of Sao Paulo General Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation13
Arthritis, Rheumatoid3
Agnosia2
Anemia, Iron-Deficiency1
Arthritis1
Arthritis, Psoriatic1
Atherosclerosis1
Chagas Disease1
Crohn Disease1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.